1 / 9

Colton ellis

Colton ellis. Business Model. Lines of Operations Generic Drugs Leading generic pharmaceutical company in the world Innovative Drugs invests in companies with promising products and technologies at the drug discovery phase Teva API (Active Pharmaceutical Ingredients)

gay-morrow
Télécharger la présentation

Colton ellis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Colton ellis

  2. Business Model Lines of Operations • Generic Drugs • Leading generic pharmaceutical company in the world • Innovative Drugs • invests in companies with promising products and technologies at the drug discovery phase • Teva API (Active Pharmaceutical Ingredients) • leading international supplier of active pharmaceutical ingredients

  3. Economic Moat Domination of the market Size and Experience Increasing demand for cheaper prescription drugs

  4. Outlook Greatest risk is the risk of Copaxone patent expiring in 2014. There is an increasing demand for generics. Large amount of R&D to develop new innovative drugs as well as active pharmaceutical ingredients.

  5. Competitors

  6. Management Acquisitions in key fields R & D spending Patents Returns

  7. Valuation

  8. Sources Bloomberg Yahoo Finance Morningstar Valueline 10-K Tevapharm.com

More Related